OIA
CBPO

Optimum Investment Advisors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Optimum Investment Advisors’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-100
Closed -$8K – 1084
2018
Q3 		$8K Buy
+100
New +$9.32K ﹤0.01% 882
2015
Q1 		$57K Buy
+600
New +$44.9K 0.02% 485

Other funds holding CBPO

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
YCMGA
York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Optimum Investment Advisors's CBPO Position: Q4 2018 in Review

Optimum Investment Advisors sold out of China Biologic Products Holdings, Inc. (CBPO) in Q4 2018, closing a stake of 100 shares — an estimated $8K sold.

Optimum Investment Advisors first reported a position in CBPO in Q1 2015 and held it in 2 quarters. The position peaked at $57K in Q1 2015. 67 funds tracked by Wall St. Rank hold CBPO as of Q4 2018.

  • Optimum Investment Advisors reported no remaining China Biologic Products Holdings, Inc. position as of Q4 2018 after selling out during the quarter.
  • Optimum Investment Advisors sold 100 China Biologic Products Holdings, Inc. shares in Q4 2018, an estimated $8K.
  • Optimum Investment Advisors first reported a position in China Biologic Products Holdings, Inc. in Q1 2015 and held it in 2 quarters.
  • Optimum Investment Advisors's China Biologic Products Holdings, Inc. position peaked at $57K in Q1 2015.
  • 67 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2018.

Based on Optimum Investment Advisors's 13F filing for Q4 2018, filed 4 Feb 2019.